Japan, July 14 -- JAPAN-MULTINATIONAL TRIAL ORGANIZATION,CANON MEDICAL SYSTEMS CORP has got intellectual property rights for 'HUMAN DENATURED CRP-SPECIFIC NEUTRALIZING ANTIBODIES AND MEDICINES AND ANTI-INFLAMMATORY AGENTS COMPRISING SAME.' Other related details are as follows:
Application Number: JP,2022-020435
Category (FI): A61K39/395@Y,A61P29/00,A61P29/00,101,A61P19/02,A61P37/02,A61K39/395@N,C12N15/13,C07K16/18,C12N15/63@Z
Stage: PROBLEM TO BE SOLVED: To provide human denatured CRP-specific neutralizing antibodies usable for drugs such as anti-inflammatory agents.SOLUTION: The invention provides: (1) an anti-inflammatory agent comprising a human denatured CRP-specific neutralizing antibody; (2) a human denatured CRP-specific neutraliz...